"Het Erasmus MC Sophia Kinderziekenhuis heeft alles in huis om uw kind de beste zorg te bieden. Het is een innovatief kinderziekenhuis, dat al meer dan 150 jaar bestaat. Alle specialismen op het gebied van kindergeneeskunde, chirurgie en kinderpsychiatrie zijn aanwezig. Ook zijn de afdelingen Verloskunde en Gynaecologie, Klinische Genetica en Urologie aanwezig in en onderdeel van het Erasmus MC-Sophia. De kennis van alle vakgebieden in het kinderziekenhuis komt samen in vier speerpunten: het Kinderthoraxcentrum, het Kinderhersencentrum, het Centrum voor Zeldzame ziekten en het Centrum voor reproductieve, foetale en neonatale geneeskunde."

During the past decade, Sophia Children's Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sophia Children's Hospital" #1 sponsor was "Colaris, Joost, M.D." with 5 trials, followed by "Ethicare GmbH" with 3 trials sponsored, "Erasmus Medical Center" with 2 trials sponsored, "Genzyme, a Sanofi Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sophia Children's Hospital" #1 collaborator was "Academy of Finland" with 1 trials as a collaborator, "BioMarin/Genzyme LLC" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Diabetes Research Foundation, Finland" with 1 trials as a collaborator and "Dutch Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Sophia Children's Hospital" are "Fracture" (5 trials), "Child" (3 trials), "Forearm" (3 trials), "Heart Failure" (3 trials) and "Treatment" (3 trials). Many other conditions were trialed in "Sophia Children's Hospital" in a lesser frequency.

Most popular intervention types in "Sophia Children's Hospital" are "Drug" (10 trials), "Procedure" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enalapril Orodispersible Minitablet" (3 trials), "Placebo" (2 trials), "1 or 2 elastic stable intramedullary nails" (1 trials), "Aldurazyme (Recombinant Human Alpha-L-Iduronidase)" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sophia Children's Hospital" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Sophia Children's Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sophia Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sophia Children's Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".